Table 5.
Pattern of acquired and initial resistance to first line anti-tuberculosis drugs in the Centre and West regions of Cameroon
| Resistance to: |
Drug(s) | Region | Acquired resistance |
% among old cases; N = 6 for Centre and 13 for West |
Initial resistance |
% among new cases; N = 68 for Centre and 62 for West |
|---|---|---|---|---|---|---|
| One drug | INH | Centre | 0 | / | 2 | 2.94 |
| West | 0 | / | 2 | 3.22 | ||
| RIF | Centre | 0 | / | 1 | 1.47 | |
| West | 0 | / | 2 | 3.22 | ||
| SM | Centre | 1 | 16.66 | 0 | 0 | |
| West | 0 | / | 1 | 1.61 | ||
| EMB | Centre | 0 | / | 0 | 0 | |
| West | 0 | / | 0 | 0 | ||
| Two drugs | INH, SM | Centre | 0 | / | 2 | 2.94 |
| West | 0 | / | 0 | 0 | ||
| INH, RIF | Centre | 0 | / | 0 | 0 | |
| West | 0 | / | 2 | 3.22 | ||
| Three drugs | INH, RIF, SM | Centre | 0 | / | 0 | 0 |
| West | 3 | 23.07 | 0 | 0 | ||
| Totals for both regions | 4 | 21.05 | 12 | 9.20 | ||
(INH) = Isoniazid; (RIF) = Rifampicin; (SM) = Streptomycin; (EMB) = Ethambutol